Hensley Mark Earl
SEC CIK 2065816 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | COO | 179.8K | — | — | 5 | 2026-04-30 | 2026-08-06 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 10:18 | 2026-08-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Hensley Mark Earl | COO | M - OptEx | — | +31.2K | 179.8K | +21% | — |
| D | 2026-08-10 10:18 | 2026-08-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Hensley Mark Earl | COO | F - Tax | $0.5 | -8,888 | 170.9K | -5% | -$4,444 |
| D | 2026-08-03 11:20 | 2026-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Hensley Mark Earl | COO | M - OptEx | — | +11.8K | 148.5K | +9% | — |
| D | 2026-05-07 13:01 | 2026-05-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Hensley Mark Earl | COO | M - OptEx | — | +125.0K | 136.8K | +1,062% | — |
| D | 2026-05-04 12:49 | 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Hensley Mark Earl | COO | M - OptEx | — | +11.8K | 11.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations